论文部分内容阅读
建厂初期仅投资60万元的南京大学制药厂,重视研制开发新产品。自1988年创建起,经过几年的努力,1995年已实现年产值1500万元,税后利润452万元,人均创利5.4万元,较1994年增长一倍多。几年来累计向南京大学净交利润600多万元,是学校投资额的10倍。药厂固定资产达1500万元。几年来开发出国家级一类新药2个,国家级五类新药1个,开发移植新产品19个,争取到国家级火炬计划项目4个。产品先后荣获南京市医药局科技进步一等奖、南京市科委科技进步一等奖、中国人民解放军总后勤部科技进步二等奖,并被评为江苏省“重合同守信用
At the beginning of the establishment, the company invested only 600,000 yuan in the pharmaceutical factory of Nanjing University and attached importance to research and development of new products. Since its establishment in 1988, after several years of efforts, it has achieved an annual output value of 15 million yuan in 1995, a profit after tax of 4.52 million yuan, and an average profit of 54,000 yuan per capita, which has more than doubled in 1994. Over the past few years, the company has made a net profit of more than RMB 6 million to Nanjing University, which is 10 times that of the school. Pharmaceutical fixed assets amounted to 15 million yuan. Over the past few years, we have developed 2 national-level new drugs, 1 national-level 5 new drugs, 19 new transplants, and 4 national torch plans. The products have won the First Prize of Science and Technology Progress Award from the Nanjing Pharmaceutical Bureau, the Science and Technology Progress First Prize of the Nanjing Science and Technology Commission, and the Second Progress Award of the Scientific and Technological Progress of the General Logistics Department of the Chinese People’s Liberation Army.